Entrega Bio

A proprietary technology that makes injectable substances available orally.

Launch date

2010

Employees

Market cap

Enterprise valuation

Boston Massachusetts (HQ)

Date	Investors	Amount	Round
Jan 2011	PureTech	$4.0m	Series A
Dec 2017	Eli Lilly	$5.0m	Early VC
Total Funding		€8.2m

Recent News about Entrega Bio